X4 Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MORGAN STANLEY | 08/13/2026 | 9.46 M | $44.18 M | -0.06% | 7.49% |
| FMR LLC | 08/13/2026 | 8.32 M | $38.86 M | 2.69% | 6.59% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 08/14/2026 | 7.97 M | $37.21 M | 0.00% | 6.31% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 7.93 M | $37.05 M | 17.75% | 6.28% |
| SATURN V CAPITAL MANAGEMENT LLC | 08/14/2026 | 6.97 M | $32.57 M | 8.00% | 5.52% |
| EMPERY ASSET MANAGEMENT, LP | 08/11/2026 | 6.93 M | $32.37 M | -22.51% | 5.49% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 5.88 M | $27.45 M | -7.27% | 4.65% |
| BLACKROCK, INC. | 08/07/2026 | 5.55 M | $25.94 M | 358.40% | 4.40% |
| KALEHUA CAPITAL MANAGEMENT LLC | 08/19/2026 | 3.72 M | $17.39 M | 0.00% | 2.95% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 3.72 M | $17.35 M | 6.24% | 2.94% |
| ROSALIND ADVISORS, INC. | 08/14/2026 | 3.21 M | $15.01 M | 0.00% | 2.54% |
| BRAIDWELL LP | 08/14/2026 | 2.92 M | $13.65 M | -10.70% | 2.31% |
| BLACKSTONE INC. | 08/14/2026 | 2.68 M | $12.52 M | 0.00% | 2.12% |
| TRAILS EDGE CAPITAL PARTNERS, LP | 08/14/2026 | 2.57 M | $12.01 M | 0.00% | 2.04% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 2.45 M | $11.44 M | 0.00% | 1.94% |
| BVF INC/IL | 08/14/2026 | 2.23 M | $10.43 M | 0.00% | 1.77% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.10 M | $9.80 M | 123.26% | 1.66% |
| VR ADVISER, LLC | 08/14/2026 | 1.93 M | $9.03 M | 485.21% | 1.53% |
| SAMSARA BIOCAPITAL, LLC | 08/14/2026 | 1.40 M | $6.52 M | -23.85% | 1.10% |
| STATE STREET CORP | 08/07/2026 | 1.30 M | $6.05 M | 221.17% | 1.03% |
| WOODLINE PARTNERS LP | 08/14/2026 | 1.00 M | $4.68 M | 0.00% | 0.79% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 916.54 K | $4.28 M | 3.90% | 0.73% |
| NORTHERN TRUST CORP | 08/13/2026 | 652.85 K | $3.05 M | 266.29% | 0.52% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 572.04 K | $2.67 M | 18.99% | 0.45% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 542.13 K | $2.53 M | 100.00% | 0.43% |
| VERDAD ADVISERS, LP | 08/14/2026 | 352.09 K | $1.64 M | 100.00% | 0.28% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 263.26 K | $1.23 M | 294.41% | 0.21% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 263.26 K | $1.23 M | 100.00% | 0.21% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 250.30 K | $1.17 M | 100.00% | 0.20% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 250.00 K | $1.17 M | 100.00% | 0.20% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 08/17/2026 | 224.99 K | $1.05 M | -32.90% | 0.18% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 196.34 K | $916.91 K | 100.00% | 0.16% |
| AFFINITY ASSET ADVISORS, LLC | 08/13/2026 | 145.00 K | $677.15 K | 0.00% | 0.11% |
| NUVEEN, LLC | 08/11/2026 | 107.39 K | $501.51 K | 100.00% | 0.09% |
| INVESCO LTD. | 08/14/2026 | 96.77 K | $451.93 K | 384.64% | 0.08% |
| ALPS ADVISORS INC | 07/29/2026 | 95.73 K | $447.04 K | 100.00% | 0.08% |
| RHUMBLINE ADVISERS | 08/12/2026 | 95.08 K | $444.02 K | 100.00% | 0.08% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 87.28 K | $407.61 K | -14.93% | 0.07% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 78.89 K | $368.39 K | 100.00% | 0.06% |
| GSA CAPITAL PARTNERS LLP | 08/06/2026 | 76.31 K | $356.00 K | 100.00% | 0.06% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 74.80 K | $349.29 K | 100.00% | 0.06% |
| CITIGROUP INC | 08/03/2026 | 70.11 K | $327.42 K | 96.04% | 0.06% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 67.71 K | $316.22 K | 100.00% | 0.05% |
| PALUMBO WEALTH MANAGEMENT LLC | 08/12/2026 | 67.12 K | $313.43 K | -48.77% | 0.05% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 67.08 K | $313.25 K | 100.00% | 0.05% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 66.38 K | $310.00 K | 100.00% | 0.05% |
| UBS GROUP AG | 08/13/2026 | 58.04 K | $271.06 K | -78.29% | 0.05% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 51.80 K | $241.91 K | 100.00% | 0.04% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 47.97 K | $224.02 K | 100.00% | 0.04% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 46.86 K | $218.84 K | -68.90% | 0.04% |
X4 Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 137 institutional investors and hedge funds held shares of X4 Pharmaceuticals Inc. The most heavily invested institutionals were:
MORGAN STANLEY: 9.46 M
FMR LLC: 8.32 M
Bain Capital Life Sciences Investors, LLC: 7.97 M
PERCEPTIVE ADVISORS LLC: 7.93 M
Saturn V Capital Management LLC: 6.97 M
Empery Asset Management, LP: 6.93 M
76.13% of X4 Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 111.34 M shares in the last 24 months. This purchase volume represents approximately $462.08 M in transactions.